- ►diabetesjournals.org RE Schmieder, C Delles, A Mimran, JP Fauvel … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—The mean ± SE fall in renal plasma flow (RPF) in response to
intravenous N G -monomethyl-l-arginine (l-NMMA), reflecting the magnitude of
nitric oxide (NO) activity, increased with telmisartan from 71.9 ± 9.0 ... Cited by 30 - Related articles - BL Direct - All 7 versions
[CITATION] Impact of Telmisartan Versus Ramipril on Renal Endothelial Function in Patients with …
- Free from Publisher H Makino, M Haneda, T Babazono, T Moriya, … - Diabetes Care, 2007 - Am Diabetes Assoc To date, evidence for long-term renoprotection with angiotensin receptor
blockers (ARBs) has come almost exclusively from Caucasian patients (1–3),
despite Japanese people being at high risk of diabetic nephropathy and very ... Cited by 35 - Related articles - BL Direct - All 6 versions
AM Sharma, J Davidson, S Koval, Y … - Cardiovascular Diabetology, 2007 - cardiab.com SMOOTH was a prospective, randomized, open-label, blinded-endpoint, multicentre
trial. After a 2- to 4-week, single-blind, placebo run-in period, patients
received once-daily telmisartan 80 mg or valsartan 160 mg for 4 weeks, with ... Cited by 14 - Related articles - Cached - All 10 versions
J Galle, S PINNETTI, C Wanner - Age (years) - bayer-bluthochdruck.de • Proteinuria is a key indicator of renal and cardiovascular health.1 Reducing
proteinuria is a central aim to prevent renal and cardiovascular disease
progression in patients with type 2 diabetes and nephropathy.2 • The ... Cited by 2 - Related articles - View as HTML - All 3 versions
M Moser, C Rosendorff, WB White - Journal of Clinical Hypertension, 2008 - hypertensionfoundation.org Dr MOsEr: Our plan is to briefly discuss how angiotensin-converting enzyme
inhibitors (aCEis) and angiotensin ii receptor blockers (arBs) work in the
treatment of hypertension and whether there is a difference in outcomes ... Cited by 2 - Related articles - View as HTML - All 5 versions
G Mancia - The Medscape Journal of Medicine, 2008 - pubmedcentral.nih.gov Cardiovascular risk is determined by multiple risk factors. Blockade of the
renin-angiotensin system is an important approach to the prevention of
cardiovascular events. In the largest angiotensin receptor blocker ... Cited by 2 - Related articles - All 4 versions
L Alcocer, P Fernandez-Bonetti, E Campos, … - International Journal of Clinical Practice, 2004 - interscience.wiley.com The efficacy and safety of once-daily telmisartan 80 mg vs. once-daily enalapril
20 mg in the treatment of essential hypertension were evaluated in a
multicentre, single-blind, placebo-controlled, randomised trial. In total, ... Cited by 2 - Related articles - BL Direct - All 5 versions
R Negro, G Formoso, H Hassan - Journal of endocrinological investigation, 2006 - ncbi.nlm.nih.gov Obesity, hypertension, dyslipidemia and glucose intolerance cluster in the
insulin resistance syndrome. Angiotensin II receptor blockers (ARB) are able to
reduce insulin resistance. Furthermore, among ARB, telmisartan displays the ... Cited by 19 - Related articles - BL Direct - All 4 versions
[CITATION] Telmisartan, an angiotensin II type 1 receptor blocker, improves endothelial function in …
